Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2020-11-20
2023-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Liquid Biopsy for NASH and Liver Fibrosis
NCT04677101
NAFLD Study: US vs Liver Biopsy
NCT04101162
Gut Microbiota and Modulation of Liver Damage in NAFLD
NCT02158351
Omics-based Predictors of NAFLD/Potential NASH
NCT05301231
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
NCT07051863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with obesity
Subjects with different classes of obesity
Liver biopsy
Biopsy of the liver to assess for Non-alcoholic steatohepatitis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liver biopsy
Biopsy of the liver to assess for Non-alcoholic steatohepatitis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Active cancer
* End stage renal failure
* End stage liver failure
* Being unable to understand and sign informed consent
19 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catholic University of the Sacred Heart
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Geltrude Mingrone
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geltrude Mingrone, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Catholic University of the Sacred Heart
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rome Sapienza
Roma, , Italy
Catholic University School of Medicine
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20202011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.